|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
Abstract |
|---|
|
|
|---|
Because dinucleotides are signaling molecules that can interact with cell surface receptors and regulate the rate of mucociliary clearance in lungs, we studied their metabolism by using
human airway epithelial cells. A membrane-bound enzyme
was detected on the mucosal surface of polarized epithelia
that metabolized dinucleotides with a broad substrate specificity (diadenosine polyphosphates and diuridine polyphosphates [UpnU], n = 2 to 6). The enzymatic reaction yielded nucleoside monophosphates (NMP) and Npn
1 (N = A or U), and
was inhibited by nucleoside 5'-triphosphates (
,
met adenosine triphosphate [ATP] > ATP
uridine triphosphate > guanidine triphosphate > cytidine triphosphate). The apparent
Michaelis constant (Km,app) and apparent maximal velocity
(Vmax,app) for [3H]Up4U were 22 ± 4 µM and 0.24 ± 0.05 nmoles · min
1 · cm
2, respectively. Thymidine 5'-monophosphate p-nitrophenyl ester and adenosine diphosphate (ADP)-
ribose, substrates of ecto alkaline phosphodiesterase I (PDE I)
activities, were also hydrolyzed by the apical surface of airway
epithelia. ADP-ribose competed with [3H]Up4U, with a Ki of
23 ± 3 µM. The metabolism of ADP-ribose and Ap4A was not
affected by inhibitors of cyclic nucleotide phosphodiesterases (3-isobutyl-1-methylxanthine, Ro 20-1724, and 1,3-dipropyl-8-p-sulfophenylxanthine), but similarly inhibited by fluoride
and N-ethylmaleimide. These results suggest that a PDE I is responsible for the hydrolysis of extracellular dinucleotides in
human airways. The wide substrate specificity of PDE I suggests that it may be involved in several signaling events on
the luminal surface of airway epithelia, including purinoceptor
activation and cell surface protein ribosylation.
| |
Introduction |
|---|
|
|
|---|
Diadenosine polyphosphates (ApnA, n = 2 to 6) are now
widely accepted as a novel class of extracellular signaling
molecules that exhibit autocrine and paracrine functions
through the activation of cell surface receptors (1). Activities ascribed to dinucleotides include modulation of platelet aggregation (3) and vascular tone (4, 5). The dinucleotide P1,P4-di(adenosine-5')tetraphosphate (Ap4A) was
reported as a full agonist of the P2Y2 receptor (6). In airways, activation of P2Y2 receptors induces Cl
secretion,
increased cilia beating frequency, and mucus secretion, functions important for mucociliary clearance (7).
The degree of phosphorylation of a dinucleotide is a key
variable in determining the cellular responses to this class
of molecules. In the cardiovascular system, P1,P2-di(adenosine-5')pyrophosphate (Ap2A) and P1,P3-di(adenosine-5')triphosphate (Ap3A) induced vasodilation, whereas Ap4A, P1,P5-di(adenosine-5')pentaphosphate (Ap5A), and
P1,P6-di(adenosine-5')hexaphosphate (Ap6A) induced
vasoconstriction (8). Dinucleotides also reduced the electrical junction potential of vas deferens smooth muscles
(Ap5A > Ap4A > Ap3A > Ap2A). The effects of Ap4A
and Ap5A were sensitive to pyridoxalphosphate-6-azophenyl-2',4'-disulfonic acid, an antagonist of P2 purinoceptors,
whereas those of Ap2A and Ap3A were sensitive to 8-(p-sulfophenyl)theophylline (8-pSPT), an antagonist of adenosine purinoceptors (P1) (9). In the guinea pig right atrium,
dinucleotides triggered a negative inotropic response
(Ap2A
adenosine triphosphate [ATP]
Ap4A = Ap3A = Ap5A). The effects of Ap2A and ATP were sensitive to
8-pSPT, whereas those of Ap3A, Ap4A, and Ap5A were
blocked by suramin, a P2 purinoceptor antagonist (10).
These studies suggest that, depending on the phosphorylation status, dinucleotides may activate both P1 and P2 purinoceptors. Alternatively, P1 purinoceptor activation may require conversion of the dinucleotide into adenosine by
cell surface enzymes.
The metabolism of extracellular dinucleotides has been
reported at the surface of vascular endothelial cells (11-
13), chromaffin cells (14, 15), and synaptosomes of the
Torpedo electric organ (16). These enzyme activities catalyze the asymmetrical cleavage of NpnN into nucleoside
monophosphates (NMP) and Npn
1 (N = A, U [uridine],
G [guanosine]; n = 2 to 6) in the presence of divalent cations, with Michaelis constant (Km) values of 0.5 to 20 µM.
Recent studies suggest that these ectoenzymes may belong to a family of glycoproteins designated as ecto alkaline
phosphodiesterase I (PDE I). Several PDE I isoforms
have been cloned and detected in mammalian tissues, including the brain, heart, intestines, liver, lungs, and vascular system (17). These proteins play important roles
under normal and pathologic conditions, such as myelin
sheath formation in the brain (21) and initiation of tumor
metastasis (23). They cleave phosphodiester bonds of nucleotides like thymidine 5'-monophosphate p-nitrophenyl
ester (TMP-pnp), as well as pyrophosphate bonds of nucleotides like nicotinamide adenine dinucleotide (NAD),
ATP, adenosine diphosphate (ADP), and nucleoside diphosphate sugars (uridine diphosphate glucose and ADP-ribose)
(17, 18, 24). Dinucleotides were reported as substrates
for PDE I purified from human plasma (28), rat liver (29),
and rat C6 glioma (30). In contrast, these purified PDE I
showed little or no activity towards RNA, adenosine
monophosphate (AMP), or cyclic AMP (cAMP) (24, 26,
28, 29). In this study, we report for the first time the metabolism of extracellular dinucleotides on the apical membrane of human airway epithelial cells. We also provide
biochemical evidence that the enzyme that mediates this
function is a PDE I.
| |
Materials and Methods |
|---|
|
|
|---|
Cell Culture
Well-differentiated cultures from passage 1 human airway epithelial cells were grown as previously described (31). In brief, nasal and bronchial cells were harvested from resected surgical specimens (32). Primary cells were isolated by protease digestion and plated on a collagen-coated tissue culture dish (5 to 10 d) in
LHC9 medium (33) containing 25 ng/ml epidermal growth factor (EGF), 50 nM retinoic acid, 40 µg/ml gentamicin, 0.5 mg/ml bovine serum albumin, 0.8% bovine pituitary extract, 50 U/ml penicillin, 50 µg/µl streptomycin, and 0.125 mg/ml amphotericin,
termed bronchial epithelial growth medium (BEGM). The cells
were trypsinized and subpassaged on porous Transwell Col filters
(diameters: well, 24 mm; pore, 0.45 µM) in an air-liquid interface
(ALI) medium. ALI was similar to BEGM, except for a 50:50
mixture of LHC basal and Dulbecco's modified Eagle's medium-high glucose as the base, amphotericin and gentamicin were omitted, and EGF concentration was reduced to 0.5 ng/ml. Enzyme assays were carried out 4 to 5 wk after the cells reached confluence.
The cultures were composed mainly of ciliated cells (> 90%) and
exhibited a transepithelial electrical resistance of at least 300
/cm2.
Lactate dehydrogenase activity was employed as a test of cellular integrity.
Dinucleotide Hydrolase Assays
The cell surfaces were rinsed three times with Krebs buffer (KRB
[in mM]): 140 Na+, 120 Cl
, 5.2 K+, 25 HCO3
, 2.4 HPO4
, 1.3 Ca2+, 1.3 Mg2+, 5.2 glucose, and 25 N-2-hydroxyethylpiperazine-
N'-ethane sulfonic acid (Hepes) (pH 7.4); and then pre-incubated
30 min in KRB (0.35 ml apical/2 ml basolateral) at 37°C (5%
CO2/95% O2). The enzyme reaction was initiated by nucleotide
addition (0.1 mM, unless stated otherwise) and stopped by transferring 25-µl aliquots to tubes containing 0.3 ml ice-cold water.
The samples were boiled for 3 min, filtered, and analyzed by reversed-phase, paired-ion high performance liquid chromatography (HPLC). For the determination of optimum pH, Hepes was
used to buffer solutions at pH 6.5 to 8.0, Tricine for solutions at
pH 8.0 and 8.5, and 2-[N-cyclohexylamino]ethanesulfonic acid
(CHES) for solutions at pH 8.5 and 9.0. In these buffers, bicarbonate was omitted for a better control of pH.
Enzyme Kinetics and Competition Assays
The kinetic parameters of dinucleotide metabolism by human bronchial epithelial cells were measured with [3H]Up4U (P1,P4-di[uridane-5']tetraphosphate). A diuridine nucleotide was chosen over a diadenosine nucleotide because of the availability of the tritiated form [3H]Up4U, which was generously provided by Inspire Inc. (Durham, NC). Competition assays were conducted with ADP-ribose and Up4U, as substrates for PDE I and ApnA hydrolase activities, respectively. The choice of ADP-ribose over TMP-pnp reflected its higher specificity for PDE I, as well as the convenience of monitoring the reaction by HPLC. Under these conditions, the metabolites of the two substrates could be distinguished on the HPLC tracings. The reactions were initiated by the addition of the two substrates previously mixed. All kinetic and competition assays were performed as stated previously for the dinucleotide hydrolase assays and in the presence of 5 U of commercial alkaline phosphatase to avoid enzyme inhibition by products of the reaction. We verified that dinucleotides and ADP-ribose were not substrates of alkaline phosphatase.
PDE I Assays
PDE I activity was measured using a modification of the method of Kelly and Butler (34). The epithelial surfaces were rinsed three times with KRB and then pre-incubated 30 min at 37°C with the same buffer (0.35 ml apical/2 ml basolateral). The enzyme reaction was initiated with 1 mM TMP-pnp and stopped by transferring an aliquot of 250 µl into a tube containing 25 µl of NaOH 10 mM. Absorbance was read at 405 nm, and the enzyme activity was quantified with a standard curve for p-nitrophenol. PDE I activity was also measured with ADP-ribose under the conditions mentioned previously for the dinucleotide hydrolase assays.
HPLC Analysis
The separation system consisted in a Dinamax C-18 column and a
mobile phase developed with buffer A (10 mM KH2PO4 and 8 mM tetrabutyl ammonium hydrogen sulfate [TBASH], pH 5.3) from 0 to 15 min, buffer B (100 mM KH2PO4, 8 mM TBASH, and 10%
MeOH, pH 5.3) from 15 to 50 min, and buffer A from 50 to 60 min. Absorbance was monitored at 254 nm with an on-line model
490 multiwavelength detector (Shimadzu Scientific Instruments
Inc., Norcross, GA), and radioactivity was determined on-line
with a Flo-One Radiomatic
detector (Packard, Canberra, Australia), as described previously (6).
Statistics
All enzyme assays were performed on cultures of differentiated
nasal or bronchial epithelial cells obtained from at least three different donors (n
3). Rates of hydrolysis were calculated from
the decrease in the amount of substrate monitored by HPLC and
presented as nmoles/min · cm2 of surface area. These values were
expressed as means ± standard error of the mean (SEM). Unpaired
Student's t tests were used to assess the significance between means.
Paired t tests were used when comparing hydrolysis rates measured
on the apical and basolateral sides of the same epithelium. All linear regressions, curve fits, and data transformations were performed with PC computer programs Origin and Sigma plot.
Materials
ADP-ribose, alpha,beta methylene ATP (
,
metATP), Ap2A,
Ap3A, Ap4A, Ap5A, Ap4, 3',5'-cyclic guanosine monophosphate,
3'5'cAMP, 1,3-dipropyl-8-p-sulfophenylxanthine (DPSPX), 3-isobutyl-1-methylxanthine (IBMX), 8-methoxymethyl-3-isobutyl-1-methylxanthine (mmIBMX), NAD, TMP-pnp, N-ethylmaleimide
(NEM), Ro 20-1724, sodium fluoride, and TBASH were obtained
from Sigma (St. Louis, MO). Mononucleotides and calf intestine
alkaline phosphatase were purchased from Boehringer (Mannheim, Germany). Tritium-labeled Up4U (1 mCi/mmol) and
UpnU (n = 2 to 6) were generously provided by Inspire, Inc. All
other reagents were of analytical grade.
| |
Results |
|---|
|
|
|---|
Distribution of Dinucleotide Hydrolase Activity in Human Airways
The metabolism of extracellular dinucleotides was first detected upon addition of 0.1 mM Ap4A to the apical surface
of human airway epithelial cells (Figure 1). The enzyme
activity was higher on bronchial (0.12 ± 0.01 nmoles · min
1 · cm
2) than on nasal (0.07 ± 0.01 nmoles · min
1 · cm
2)
cells. In contrast, Ap4A was not hydrolyzed by the basolateral surfaces of either cell type over a 60-min incubation.
The protein responsible for Ap4A hydrolysis in human airways is an ectoenzyme for the following reasons: (1) the
substrate was hydrolyzed by intact cells and the products
were released in the extracellular milieu; (2) the amount of
substrate hydrolyzed over 60 min followed a linear relationship over time, making it unlikely that a significant amount of the substrate had been hydrolyzed after entering the cells; and (3) the rate of Ap4A hydrolysis measured
in buffer, collected after 60 min of incubation on the cells,
corresponded to less than 4% of the total cell surface enzyme activity (data not shown). Thus, human airway epithelial cells possess a membrane-bound ecto dinucleotide
hydrolase activity located on the apical surface.
|
Substrate Specificity and Mode of Action
The metabolism of ApnA on human bronchial epithelial
cells was examined by HPLC. Representative chromatographic profile sets obtained for Ap3A, Ap4A, and Ap5A
after 0, 20, and 40 min of incubation on the cells are shown
in Figure 2. The major products of Ap3A hydrolysis were
ADP and adenosine. The mass of AMP remained very small throughout the incubation period, probably due to
the high rate of degradation by an ecto-5'-nucleotidase. In
the case of Ap4A, the major peaks were ADP and adenosine, with small peaks of AMP and ATP. The presence of
ATP suggests that the enzyme cleaved Ap4A into ATP
and AMP, and not into two ADPs. Finally, the metabolism of Ap5A led to the accumulation of Ap4, and smaller
amounts of ATP, ADP, AMP, and adenosine. Altogether,
these results demonstrate that the ectoenzyme proceeds
by an asymmetrical mode of cleavage, with AMP and
Apn
1 as products of the reaction.
|
Human airway epithelial cells hydrolyzed both diadenosine and diuridine polyphosphates bearing two to six phosphate groups (Figures 3A and 3B). Diadenosine polyphosphates were hydrolyzed on average 20% more rapidly than diuridine polyphosphates, when values were compared for dinucleotides containing the same number of phosphates. In addition, the rates of hydrolysis were inversely related to the length of the phosphate chain.
|
We conducted a series of experiments to investigate
whether the relationship between phosphate chain length
and hydrolysis rates could be explained by product inhibition. First, addition of commercial alkaline phosphatase
(5 U) to efficiently remove any nucleotide formed during
the reaction accelerated the metabolism of [3H]Up4U
(Figure 3C). We verified that alkaline phosphatase had no
hydrolytic activity toward dinucleotides in vitro (data not shown). Second, addition of 0.1 mM uridine nucleotides
decreased the rate of 0.1 mM [3H]Up4U hydrolysis in the
order of potency: uridine triphosphate (UTP) > uridine
diphosphate (UDP) > uridine monophosphate (UMP) (Figure 3C). These results show that the rate of hydrolysis
of dinucleotides was inversely related to the degree of
phosphorylation of the mononucleotides. Third, we tested
whether other nucleoside triphosphates could affect the
rate of [3H]Up4U hydrolysis. All nucleotides slowed
[3H]Up4U hydrolysis in the order of potency:
,
metATP > ATP
UTP > guanidine triphosphate (GTP) > cytidine
triphosphate (CTP) (Figure 3D). Together, these results
demonstrate that the rate of dinucleotide hydrolysis was
limited by product inhibition. Consequently, most endogenous nucleotides would be expected to modulate the metabolism of extracellular dinucleotides on airway epithelia.
Kinetic Analysis of Dinucleotide Metabolism
The kinetic properties of the ectodinucleotide hydrolase
activity were examined on human bronchial epithelial cells.
The metabolism of [3H]Up4U followed simple Michaelis-Menten kinetics, and saturation was reached with 1 mM
substrate (Figure 4A). Regression analysis of a Woolf-
Augustinson Hoftsee transformation provided an apparent Michaelis constant (Km,app) of 22 ± 4 µM and an apparent
maximal velocity (Vmax,app) of 0.24 ± 0.05 nmoles · min
1 · cm
2 (Figure 4A, insert). The hydrolysis of [3H]Up4U was
inhibited by Ap2A and Ap6A, with inhibition constant (Ki)
values of 26 ± 3 and 19 ± 2 µM, respectively. The competitive pattern of inhibition is illustrated by the Dixon plot
obtained with Ap6A (Figure 4B). Because these values are
close to the Km,app calculated for [3H]Up4U, they can be
considered as indirect but accurate estimations of Km,app
for Ap2A and Ap6A. Together, these results suggest that a
single enzyme would be responsible for the metabolism of
diadenosine and diuridine polyphosphates on human airway epithelial cells.
|
Effects of Cations and pH on Ap4A Hydrolysis
The metabolism of extracellular dinucleotides by human airway epithelial cells requires the presence of divalent cations. Ap4A hydrolysis measured in KRB containing 1.3 mM Ca2+ and 1.3 mM Mg2+ was completely abolished by the addition of 5 mM ethylenediaminetetraacetic acid (EDTA). Both Mg2+ and Ca2+ were enzyme activators, with half-effective concentration (EC50) values of 0.8 and 0.4 mM, respectively (Figure 5A). With Mn2+, a sharp peak of activity was reached at about 0.5 mM, whereas higher concentrations produced lower rates of hydrolysis. The effect of pH on Ap4A hydrolysis was examined in the range 6.5 to 9.5 (Figure 5B). The ectoenzyme reached maximum activity at a pH of 9.0. A threefold increase in enzyme activity was observed by raising the pH from 7.5 to 9.0.
|
Presence of a PDE I on Human Airway Epithelium
Human bronchial epithelial cells hydrolyzed two substrates of PDE I, TMP-pnp (1 mM; 0.07 ± 0.01 nmoles · min
1 · cm
2) and ADP-ribose (1 mM; 0.32 ± 0.03 nmoles · min
1 · cm
2). The metabolism of ADP-ribose was restricted to the apical surface, and the enzyme activity was
higher on bronchial than on nasal cells (Figure 6A). ADP-ribose hydrolysis led to the production of AMP and ribose-5-phosphate (35). Whereas the latter cannot be detected by ultraviolet absorbance on the HPLC, we monitored the accumulation of AMP and the conversion of the
monophosphate into adenosine (Figure 6B). These results
support the presence of a PDE I activity on airway epithelia that shares the same distribution and asymmetrical
mode of cleavage with the dinucleotide hydrolase activity.
|
We therefore performed competition studies to investigate whether the same enzyme could be responsible for the metabolism of dinucleotides and ADP-ribose. The rate of ADP-ribose hydrolysis was reduced by increasing concentrations of Up4U and vice versa (Figures 7A and 7B). The highest concentration (1 mM) of Up4U (Figure 7A) or ADP-ribose (Figure 7B) almost completely blocked the reaction (> 95%), which suggests that a single enzyme hydrolyzed dinucleotides and ADP-ribose. Dixon plot analysis confirmed that ADP-ribose acted as a competitive inhibitor of Up4U hydrolysis, with a Ki of 23 ± 3 µM (Figure 7C).
|
Table 1 compares the effects of selected inhibitors on
the metabolism of ADP-ribose and Ap4A. The two enzyme reactions were similarly inhibited by sodium fluoride
(EC50
0.9 to 1.0 mM) and NEM (EC50
5 mM). Ap4A
and ADP-ribose hydrolysis were not affected by inhibitors
of cyclic nucleotide phosphodiesterases (DPSPX, IBMX,
and Ro 20-1724). In addition, cAMP and cGMP were not
hydrolyzed by nasal or bronchial epithelial cells (data not shown), which rules out the involvement of an extracellular cyclic nucleotide phosphodiesterase in the hydrolysis of
ADP-ribose or dinucleotides. Together, these results suggest that a PDE I was responsible for the metabolism of
extracellular diadenosine and diuridine polyphosphates on
the apical membrane of human airway epithelial cells.
Messenger RNA for two PDE I (PC-1 and PD-1
) was detected in human nasal epithelial cells by reverse transcriptase/polymerase chain reaction (data not shown).
|
| |
Discussion |
|---|
|
|
|---|
The initial focus of this study was to investigate the metabolism of putative regulators of P2Y2 receptors, dinucleotides, by human airway epithelia. Nasal and bronchial epithelial cells exhibited an ectoenzyme activity that was
restricted to the luminal surface, and that effected an
asymmetrical cleavage of dinucleotides (NpnN; N = A or
U) into NMP and Npn
1. The mononucleotides derived
from the hydrolysis of Np2N, Np3N, and Np4N were efficiently dephosphorylated into adenosine or uridine by
other ectonucleotidases previously reported on the luminal surface of airway epithelial cells (36). In contrast,
the metabolism of longer dinucleotides (Ap5A and Ap6A)
led to the accumulation of Ap4 and Ap5, suggesting that
highly phosphorylated nucleotides were poor substrates
for ectonucleotidases on airway epithelial cells. Similar
findings have been reported for endothelial cells (11).
In contrast, ApnA hydrolysis on chromaffin cells led to the
accumulation of AMP, suggesting that the ecto-5'-nucleotidase activity was a limiting step in the production of adenosine (14, 15).
The dinucleotide hydrolase activity we measured on
airway epithelia shares several properties with ecto ApnA
hydrolases reported on endothelial cells (11), chromaffin cells (14, 15), and Torpedo synaptosomes (16): an asymmetrical mode of cleavage, a broad substrate specificity,
and inhibition by ATP and ATP analogues. We also
showed that the metabolism of extracellular dinucleotides on airway epithelia was inhibited by all nucleoside triphosphates tested (
,
metATP > ATP > UTP > GTP > CTP). Moreover, Up4U hydrolysis was inhibited by uridine nucleotides in the order of potency: UTP > UDP > UMP. Therefore, the rate of dinucleotide hydrolysis was
inversely related to the degree of phosphorylation of the products of the reaction. Altogether, these results suggest
that the metabolism of extracellular dinucleotides in vivo
could be modulated by endogenously released or produced extracellular nucleotides.
The reported dinucleotide hydrolase activities can be distinguished on the basis of their substrate affinity and ion sensitivity. The substrate affinity of the airway dinucleotide hydrolase falls within the range reported for the porcine and bovine aorta endothelial enzymes, with Km values of 20 µM for Ap3A (11) and 10 µM for Ap4A (12), respectively. The ecto ApnA hydrolases of adrenomedullary endothelial cells (13), chromaffin cells (14, 15), and Torpedo presynaptic membranes (16) exhibit higher affinities, with an overall Km/Ki range of 0.5 to 7 µM for Ap2A, Ap3A, Ap4A, Ap5A, and Ap6A. We also observed that the airway dinucleotide hydrolase activity required millimolar concentrations of divalent cations (Mg2+ > Ca2+ > Mn2+) and was inhibited by fluoride (IC50 of 1 mM). Whereas these ionic properties correspond to those of the Torpedo ApnA hydrolase (16), the endothelial ecto ApnA hydrolases were inhibited by Ca2+ (12, 13), and the chromaffin ecto ApnA hydrolase was not affected by fluoride (15). Such diversity in biochemical properties supports the existence of different dinucleotide hydrolase isoforms or enzymes.
We therefore performed a series of experiments that
appeared to identify the ectoenzyme responsible for dinucleotide metabolism on human airways as a PDE I. First,
PDE I purified from human plasma (28), rat liver (29),
small intestine, and testis (18) was shown to hydrolyze
NAD, ADP-ribose, ATP, UTP, TMP-pnp, and dinucleotides, but not cyclic nucleotides. Human bronchial epithelia exhibited a similar pattern, hydrolyzing dinucleotides, TMP-pnp, and ADP-ribose, but not cAMP or
cGMP. Second, the substrate affinity of the purified liver
PDE I for dinucleotides falls within the range we report
for the airway dinucleotide hydrolase, with Km values of
8 to 22 µM for Ap2A, Ap3A, and Ap4A (29). Third, as we observed on airway epithelia, the rate of dinucleotide
hydrolysis by PDE I was inversely related to the length of
the phosphate chain, and the reaction was inhibited by
,
metATP (18). Finally, human plasma (28) and rat liver
(29) PDE I exhibited a pH optimum (8.5 to 9.0) in the
same range as the airway enzyme.
These comparisons strongly suggest the presence of a PDE I on airway epithelial cells. However, because our studies were conducted on intact cells, the possibility remained that two distinct enzymes could be responsible for the metabolism of dinucleotides and ADP-ribose, an ecto ApnA hydrolase and a PDE I, respectively. To address this possibility, we tested whether the two substrates competed for the same catalytic site. Simultaneous addition of Up4U and ADP-ribose on the apical membrane of human bronchial epithelia reduced both rates of hydrolysis. The most compelling evidence of the presence of a single enzyme was the nearly complete inhibition (> 95%) of 0.1 mM Up4U hydrolysis by 1 mM ADP-ribose and vice versa. Enzyme kinetic analyses indicated that ADP-ribose acted as a competitive inhibitor for Up4U hydrolysis, with a Ki of 23 µM. Together, these results demonstrate that the ectodinucleotide hydrolase activity we characterized on human airway epithelia is a PDE I.
In summary, we report for the first time the metabolism
of extracellular dinucleotides on the luminal surface of human airway epithelia. We also provide biochemical evidence
that this enzyme belongs to the PDE I family, as reported recently for the chromaffin cell ecto dinucleotide hydrolase
(39). The wide substrate specificity of PDE I suggests that
the enzyme may be involved in other signaling events, in addition to regulating concentrations of purinoceptor agonists.
For instance, PDE I could be involved in the ADP-ribosylation of cell surface proteins (40). ADP-ribosyl transferases
(ART) use extracellular NAD+ to transfer ADP-ribose to
arginine residues. Removal of AMP from the bound ADP-ribose by PDE I renders the protein unavailable for further
ribosylation. Reported extracellular ribosylation targets include the lymphocyte-associated molecule-1 (41) and the extracellular domain of integrin
7
1 (42). Three members of
the ART family were recently localized on human bronchial
epithelial cells: ART1, ART3, and ART4 (43). Given that
airway epithelia play an active role in inflammatory processes by recruiting and interacting with leukocytes and
macrophages, this ART-PDE I enzyme system could be involved in the regulation of immune responses via cell-to-cell
and cell-matrix interactions.
| |
Footnotes |
|---|
Address correspondence to: Maryse Picher, Cystic Fibrosis/Pulmonary Research and Treatment Center, School of Medicine, University of North Carolina, 7017 Thurston-Bowles Building, Chapel Hill, NC 27599. E-mail: pichm{at}med.unc.edu
(Received in original form December 30, 1999 and in revised form March 28, 2000).
Abbreviations: adenosine diphosphate, ADP; adenosine monophosphate, AMP; P1,P2-di(adenosine-5')pyrophosphate, Ap2A; P1,P3-di(adenosine-5')triphosphate, Ap3A; P1,P4-di(adenosine-5')tetraphosphate, Ap4A; P1,P5- di(adenosine-5')pentaphosphate, Ap5A; P1,P6-di(adenosine-5')hexaphosphate, Ap6A; adenosine triphosphate, ATP; ADP-ribosyl transferase, ART; cyclic AMP, cAMP; cyclic guanosine monophosphate, cGMP; cytidine triphosphate, CTP; 1,3-dipropyl-8-p-sulfophenylxanthine, DPSPX; guanidine triphosphate, GTP; high performance liquid chromatography, HPLC; 3-isobutyl-1-methylxanthine, IBMX; Michaelis constant, Km; inhibition constant, Ki; Krebs buffer, KRB; 8-methoxymethyl-3-isobutyl-1-methylxanthine, mmIBMX; nicotinamide adenine dinucleotide, NAD; N-ethylmaleimide, NEM; phosphodiesterase I, PDE I; tetrabutyl ammonium hydrogen sulfate, TBASH; thymidine 5'-monophosphate p-nitrophenyl ester, TMP-pnp; 8-(p-sulfophenyl)theophylline, 8-pSPT; uridine diphosphate, UDP; uridine monophosphate, UMP; uridine triphosphate, UTP, P1,P4-di(uridine-5')tetraphosphate, Up4U.Acknowledgments: The authors thank Janet Rideout and Eduardo Lazarowski for critical reading of the manuscript. This work was supported by grant CFF R026 from the Cystic Fibrosis Foundation, by grant 33242 from the National Heart, Lung and Blood Institute, and by Inspire Pharmaceuticals.
| |
References |
|---|
|
|
|---|
1. Ogilvie, A. 1992. Extracellular functions of ApnA. In Ap4A and Other Dinucleoside Polyphosphates. A. G. McLennan, editor. CRC Press, Boca Raton, Florida. 229-274.
2. Pintor, J., and M. T. Miras-Portugal. 1995. P2 purinergic receptors for diadenosine polyphosphates in the nervous system. Gen. Pharmacol. 26: 229-235 [Medline].
3. Ogilvie, A., R. Blasius, E. Schulze-Lohoff, and R. B. Sterzel. 1996. Adenine dinucleotides: a novel class of signaling molecules. J. Auton. Pharmacol. 16: 325-328 [Medline].
4.
Busse, R.,
A. Ogilvie, and
U. Pohl.
1988.
Vasomotor activity of diadenosine
triphosphate and diadenosine tetraphosphate in isolated arteries.
Am. J. Physiol.
254:
H828-H832
5. Ralevic, V., C. H. Hoyle, and G. Burnstock. 1995. Pivotal role of phosphate chain length in vasoconstrictor versus vasodilator actions of adenine nucleotides in rat mesenteric arteries. J. Physiol. (Lond.) 483: 703-713 [Medline].
6. Lazarowski, E. R., W. C. Watt, M. J. Stutts, R. C. Boucher, and T. K. Harden. 1995. Pharmacological selectivity of the cloned human P2U- purinoceptor: potent activation by diadenosine tetraphosphate. Br. J. Pharmacol. 116: 1619-1627 [Medline].
7. Donaldson, S. H., and R. C. Boucher. 1998. Therapeutic applications for nucleotides in lung disease. In The P2 Nucleotide Receptors. J. T. Turner, G. A. Weisman, and J. S. Fedan, editors. Humana Press, Totowa, NJ. 440.
8. Schlüter, H., E. Offers, G. Bruggemann, M. van der Giet, M. Tepel, E. Nordhoff, M. Karas, C. Spieker, H. Witzel, and W. Zidek. 1994. Diadenosine phosphates and the physiological control of blood pressure. Nature 367: 186-188 [Medline].
9. Hoyle, C. H., A. Postorino, and G. Burnstock. 1995. Pre- and postjunctional effects of diadenosine polyphosphates in the guinea-pig vas deferens. J. Pharm. Pharmacol. 47: 926-931 [Medline].
10. Hoyle, C. H., A. U. Ziganshin, J. Pintor, and G. Burnstock. 1996. The activation of P1- and P2-purinceptors in the guinea-pig left atrium by diadenosine polyphosphates. Br. J. Pharmacol. 118: 1294-1300 [Medline].
11.
Goldman, S. J.,
E. L. Gordon, and
L. L. Slakey.
1986.
Hydrolysis of diadenosine 5',5
-P',P
-triphosphate (Ap3A) by porcine aortic endothelial cells.
Circ. Res.
59:
362-366
12. Ogilvie, A., J. Luthje, U. Pohl, and R. Busse. 1989. Identification and partial characterization of an adenosine(5')tetraphospho(5')adenosine hydrolase on intact bovine aortic endothelial cells. Biochem. J. 259: 97-103 [Medline].
13.
Mateo, J.,
M. T. Miras-Portugal, and
P. Rotllan.
1997.
Ecto-enzymatic hydrolysis of diadenosine polyphosphates by cultured adreno-medullary vascular endothelial cells.
Am. J. Physiol.
273:
C918-C927
14. Rodriguez-Pascual, F., M. Torres, P. Rotllan, and M. T. Miras-Portugal. 1992. Extracellular hydrolysis of diadenosine polyphosphates, ApnA, by bovine chromaffin cells in culture. Arch. Biochem. Biophys. 297: 176-183 [Medline].
15. Ramos, A., J. Pintor, M. T. Miras-Portugal, and P. Rotllan. 1995. Use of fluorogenic substrates for detection and investigation of ectoenzymatic hydrolysis of diadenosine polyphosphates: a fluorometric study on chromaffin cells. Anal. Biochem. 228: 74-82 [Medline].
16. Mateo, J., P. Rotllan, E. Marti, I. Gomez De Aranda, C. Solsona, and M. T. Miras-Portugal. 1997. Diadenosine polyphosphate hydrolase from pre-synaptic plasma membranes of Torpedo electric organ. Biochem. J. 323: 677-684 .
17.
Haugen, H. F., and
S. Skrede.
1977.
Nucleotide pyrophosphatase and phosphodiesterase I: organ distribution and activities in body fluids.
Clin. Chem.
23:
1531-1537
18.
Nakabayashi, T., and
H. Ikezawa.
1986.
Alkaline phosphodiesterase I release from eucaryotic plasma membranes by phosphatidylinositol-specific
phospholipase C: I. The release from rat organs.
J. Biochem.
99:
703-712
19. Gross, S. C., M. Watabe, G. Goodarzi, A. Darabi, and K. Watabe. 1990. Organ-specific distribution of isozymes of 5'-nucleotide phosphodiesterase in mouse. Comp. Biochem. Physiol. [B] 95: 821-824 [Medline].
20. Morley, D. J., D. M. Hawley, T. M. Ulbright, L. G. Butler, J. S. Culp, and M. E. Hodes. 1987. Distribution of phosphodiesterase I in normal human tissues. J. Histochem. Cytochem. 35: 75-82 [Abstract].
21.
Fuss, B.,
H. Baba,
T. Phan,
V. K. Tuohy, and
W. B. Macklin.
1997.
Phosphodiesterase I, a novel adhesion molecule and/or cytokine involved in
oligodendrocyte function.
J. Neurosci.
17:
9095-9103
22.
Buckley, M. F.,
K. A. Loveland,
W. J. McKinstry,
O. M. Garson, and
J. W. Goding.
1990.
Plasma cell membrane glycoprotein PC-1: cDNA cloning of
the human molecule, amino acid sequence, and chromosomal location.
J.
Biol. Chem.
265:
17506-17511
23.
Stracke, M. L.,
H. C. Krutzsch,
E. J. Unsworth,
A. Arestad,
V. Cioce,
E. Schiffmann, and
L. A. Liotta.
1992.
Identification, purification and partial
sequence analysis of autotaxin, a novel motility-stimulating protein.
J.
Biol. Chem.
267:
2524-2529
24. Evans, W. H., D. O. Hood, and J. W. Gurd. 1973. Purification and properties of a mouse liver plasma-membrane glycoprotein hydrolyzing nucleotide pyrophosphate and phosphodiester bonds. Biochem. J. 135: 819-826 [Medline].
25. Rebbe, N. F., B. D. Tong, and S. Hickman. 1993. Expression of nucleotide pyrophosphatase and alkaline phosphodiesterase I activities of PC-1, the murine plasma cell antigen. Mol. Immunol. 30: 87-93 [Medline].
26. Bischoff, E., J. Wilkening, T. A. Tran-Thi, and K. Decker. 1976. Differentiation of the nucleotide pyrophosphatases of rat-liver plasma membranes and endoplasmic reticulum by enzymic iodination. Eur. J. Biochem. 62: 279-283 [Medline].
27.
Clair, T.,
H. Y. Lee,
L. A. Liotta, and
M. L. Stracke.
1997.
Autotaxin is an
exoenzyme possessing 5'-nucleotide phosphodiesterase/ATP pyrophosphatase and ATPase activities.
J. Biol. Chem.
272:
996-1001
28. Luthje, J., and A. Ogilvie. 1985. Catabolism of Ap3A and Ap4A in human plasma: purification and characterization of a glycoprotein complex with 5'-nucleotide pyrophosphatase activity. Eur. J. Biochem. 149: 119-127 [Medline].
29.
Cameselle, J. C.,
M. J. Costas,
M. A. Gunther,
Sillero, and
A. Sillero.
1984.
Two
low Km hydrolytic activities on dinucleoside 5',5'''-P1,P4-tetraphosphates in
rat liver: characterization as the specific dinucleoside tetraphosphatase and a
phosphodiesterase I-like enzyme.
J. Biol. Chem.
259:
2879-2885
30. Grobben, B., K. Anciaux, D. Roymans, C. Stefan, M. Bollen, E. L. Esmans, and H. Slegers. 1999. An ecto-nucleotide pyrophosphatase is one of the main enzymes involved in the extracellular metabolism of ATP in rat C6 glioma. J. Neurochem. 72: 826-834 [Medline].
31. Gray, T. E., K. Guzman, C. W. Davis, L. H. Abdullah, and P. Nettesheim. 1996. Mucociliary differentiation of serially passaged normal human tracheobronchial epithelial cells. Am. J. Respir. Cell Mol. Biol. 14: 104-112 [Abstract].
32. Wu, R., J. Yankaskas, E. Cheng, M. R. Knowles, and R. C. Boucher. 1985. Growth and differentiation of human nasal epithelial cells in culture: serum-free, hormone-supplemented medium and proteoglycan synthesis. Am. Rev. Respir. Dis. 132: 311-320 [Medline].
33. Lechner, J. F., and M. A. LaVeck. 1985. A serum-free method for culturing normal human bronchial epithelial cells at clonal density. Journal Tissue Culture Methods 9: 43-48 .
34. Kelly, S. J., and L. G. Butler. 1975. Enzymic hydrolysis of phosphonate esters. Biochem. Biophys. Res. Commun. 66: 316-321 [Medline].
35. Deterre, P., L. Gelman, H. Gary-Gouy, C. Arrieumerlou, V. Berthelier, J.-M. Tixier, S. Ktorza, J. Goding, C. Schmitt, and G. Bismuth. 1996. Coordinated regulation of human T cells of nucleotide-hydrolyzing ecto-enzymatic activities, including CD38 and PC-1. J. Immunol. 157: 1381-1388 [Abstract].
36.
Sevigny, J.,
M. Picher,
G. Grondin, and
A. R. Beaudoin.
1997.
Purification
and immunohistochemical localization of the ATP-diphosphohydrolase in
bovine lungs.
Am. J. Physiol.
272:
L939-L950
37. Resta, R., S. W. Hooker, K. R. Hansen, A. B. Laurent, J. L. Park, M. R. Blackburn, T. B. Knudsen, and L. F. Thompson. 1993. Murine ecto-5'- nucleotidase (CD73): cDNA cloning and tissue distribution. Gene 133: 171-177 [Medline].
38. Franco, R., V. Casado, F. Ciruela, C. Saura, J. Mallol, E. I. Canela, and C. Lluis. 1997. Cell surface adenosine deaminase: much more than an ectoenzyme. Prog. Neurobiol. 52: 283-294 [Medline].
39. Gasmi, L., J. L. Cartwright, and A. G. McLennan. 1998. The hydrolytic activity of bovine adrenal medullary plasma membranes toward diadenosine polyphosphates is due to alkaline phosphodiesterase-I. Biochim. Biophys. Acta 1405: 121-127 [Medline].
40. Moss, J., E. Balducci, E. Cavanaugh, H. J. Kim, P. Konczakik, E. A. Lesma, I. J. Okazaki, M. Park, M. Shoemaker, L. A. Stevens, and A. Zolkiewska. 1999. Characterization of NAD:arginine ADP-ribosyltransferases. Mol. Cell. Biochem. 193: 109-113 [Medline].
41. Nemeto, E., Y. Yu, and G. Dennert. 1996. Cell surface ADP-ribosyltransferase regulates lymphocyte function-associated molecule-1 (LFA-1) function in T cells. J. Immunol. 157: 3341-3349 [Abstract].
42.
Zolkiewska, A., and
J. Moss.
1993.
Integrin
7 as a substrate for a glycosylphosphatidyl inositol-anchored ADP-ribosyltransferase on the surface
of skeletal muscle cells.
J. Biol. Chem.
268:
25273-25276
43.
Balducci, E.,
K. Horiba,
J. Usuki,
M. Park,
V. J. Ferrans, and
J. Moss.
1999.
Selective expression of RT6 superfamily in human bronchial epithelial
cells.
Am. J. Respir. Cell Mol. Biol.
21:
337-346
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Crit. Care Med. |